Usual values for 5-hydroxy-indol acetic acid and homovanillic acid in cerebrospinal fluid;Établissement de valeurs usuelles pour les acides 5-hydroxyindolacétique et homovanillique dans le liquide céphalorachidien

Annales de Biologie Clinique

Volumn 61, Issue 1, 2003, Pages 69-75

  Dhondt, J L ^a   Forzy, G ^a  

^a Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

5 hydroxyindoleacetic acid; Cerebrospinal fluid; Homovanillic acid; Neurotransmitters; Usual values

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID;

ADOLESCENT; ADULT; AGING; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CHILD; ELECTROCHEMISTRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; METHODOLOGY; MIDDLE AGED; NEWBORN; PREMATURITY; PRESCHOOL CHILD; REFERENCE VALUE; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGING; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0037261916     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Henny J, Petitclerc C, Fuentes-Arderiu X. et al. Réviser le concept de valeurs de référence: une nécessité. Ann Biol Clin 2001 ; 59 : 383-92.
2. Bräutigam G, Weykamp C, Hoffmann GF, Wevers RA. Neurotransmitter metabolites in CSF: an external quality control scheme. J Inher Metab Dis 2002 ; 25 : 287-98.
3. Dhondt JL, Forzy G, Hayte JM, Farriaux JP, Largillière C. Pterins and monoamine metabolites in cerebrospinal fluid. In: Curtius H Ch, Blau N, eds. Unconjugated pterins and related biogenic amines. Berlin : W deGruyter, 1987 : 367-74.
4. Forzy G, Dhondt JL, Hayte JM. Comparaison de onze détecteurs électrochimiques utilisés en chromatographie liquide haute performance. Ann Biol Clin 1988 ; 46 : 793-99.
5. Millot F, Dhondt JL, Mazingue F. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia. Leuk Lymphoma 1993 ; 9 : 351-6.
6. Dhondt JL, Farriaux JP, Millot F, Taret S, Hayte JM, Mazingue F. Méthotrexate à haute dose et hyperphénylalaninémie. Arch Fr Pediatr 1991 ; 48 : 249-51.
7. Millner MM, Franthal W, Thalhammer GH, et al. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998 ; 44 : 161-7.
8. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993 ; 168 : 1285-8.
9. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001 ; 47 : 2137-45.
10. Scheinin M. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Med Biol 1985 ; 63 : 1-17.
11. Wood JH. Neurochemical analysis of cerebrospinal fluid. Neurology 1980 ; 30 : 645-51.
12. Amin F, Davidson M, Davis KL. Homovanillic acid measurement in clinical research: a review of methodology. Schizophrenia Bulletin 1992; 18: 123-48.
13. Commission «valeurs de référence». Le concept de valeurs de référence en biologie clinique. Ann Biol Clin 1981 ; 39 : 381-4.
14. Hartikainen P, Reinikainen KJ, Soininen H, Sirviö J, Soikkeli R, Riekkinen PJ. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls. J Neural Transm 1992 ; 4 : 53-68.
15. Kirwin PD, Anderson GM, Chappell PB, et al. Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females. Life Sci 1997 ; 60 : 899-907.
16. Komori H, Matsuishi T, Yamada S, Ichikawa K, Amamoto M, Yamashita F. Elevated biopterin and homovanillic acid levels in cerebrospinal fluid from children with aseptic meningitis. J Child Neurol 1994 ; 9 : 22-5.
17. Blennow K, Wallin A, Gottfries CG, Mansson JE, Svennerholm L. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm Park Dis Dement Sect 1993 ; 5 : 5-15.
18. Corona GL, Cucchi ML, Frattini P, et al. Monoamine metabolites in biological fluids of multiple sclerosis patients. Biogenic Amines 1991 ; 8 : 127-33.
19. Markianos M, Seretis A, Kotsou S, Baltas I, Sacharogiannis H. CSF neurotransmitter metabolites and short-term outcome of patients in coma after head injury. Acta Psychiatr Scand 1992 ; 86 : 190-3.
20. Parnetti L, Gaiti A, Reboldi GP, et al. CSF monoamine metabolites in old age dementias. Mol Chem Neuropathol 1992; 16: 143-57.
21. Langlais PJ, Wardlow ML, Yamamoto H. Changes in CSF neurotransmitters in infantile spasms. Pediatr Neurol 1991 ; 7 : 440-5.
22. Blennow K, Wallin A, Gottfries CG, et al. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Neurobiol Aging 1992 ; 13:107-13.
23. Reimherr FW, Wender PH, Ebert MH, Wood DR. Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Research 1984 ; 11 : 71-8.
24. Lekman A, Witt-Engerstrom I, Hagberg B. CSF and urine biogenic amine metabolites in Rett syndrome. Clin Genet 1990 ; 37 : 173-8.
25. Javors MA, Bowden CL, Maas JW. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reverse-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard. J Chromatogr 1984 ; 336 : 259-70.
26. Andersen O, Johansson B, Svennerholm L. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis. Acta Neurol Scand 1981 ; 63 : 247-54.
27. Blennow K, Wallin A, Gottfries CG, et al. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. Eur Neuropsychopharmacol 1993 ; 3 : 55-61.
28. Blennow K, Wallin A, Gottfires CG, et al. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Neurobiol Aging 1991 ; 13 : 107-13.
29. Hildebrand J, Bourgeois F, Goldman S. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid. Acta Neurol Scand 1990 ; 81 : 427-30.
30. Hoffmann GF, Surtees RA, Wevers RA. Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 1998 ; 29 : 59-71.